SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105013371> ?p ?o ?g. }

Showing items 1 to 100 of ±117 with 100 items per page.

W2105013371 endingPage "730" @default.
W2105013371 startingPage "722" @default.
W2105013371 abstract "Intermittent androgen deprivation (IAD) in prostate cancer (PCa) patients has been proposed to delay development of castration resistance and to reduce the side effects and costs of androgen deprivation therapy (ADT). This review analyzes (1) the oncologic and quality of life (QoL) results from randomized phase 3 trials comparing IAD and continuous ADT and (2) the prognostic parameters for IAD. We searched the Medline and Cochrane Library databases (primary fields: prostate neoplasm and intermittent androgen deprivation; secondary fields: randomized trials, survival, quality of life, predictors) without language restriction. We found seven extensively described phase 3 trials randomizing 4675 patients to IAD versus continuous ADT. Other randomized trials investigating IAD have been performed, but available data are limited and have been published only in preliminary fashion. In all seven trials, patients spent most of their time on, rather than off, ADT. The induction periods ranged from 3 mo to 8 mo; in all but one trial, the PSA level designated for ADT discontinuation was <4 ng/ml. Mean follow-up ranged from 40–108 mo. Collectively, these trials support the concept that, mainly in metastatic cases, IAD can produce oncologic results similar to continuous ADT. In terms of overall survival, the hazard ratios for IAD and continuous ADT were very similar (range: 0.98–1.08). The QoL benefit of IAD appears to be modest at best. With IAD, QoL is likely influenced by the duration of the off-treatment periods and by the rate of testosterone recovery. The evidence indicates that IAD is not inferior to continuous ADT. Data are insufficient to determine whether IAD is able to prevent the long-term complications of ADT. More comparative analysis focused on QoL is warranted." @default.
W2105013371 created "2016-06-24" @default.
W2105013371 creator A5002009939 @default.
W2105013371 creator A5018275141 @default.
W2105013371 creator A5053854071 @default.
W2105013371 creator A5054920808 @default.
W2105013371 creator A5057812789 @default.
W2105013371 creator A5073246821 @default.
W2105013371 creator A5081220576 @default.
W2105013371 creator A5082556049 @default.
W2105013371 date "2013-11-01" @default.
W2105013371 modified "2023-10-14" @default.
W2105013371 title "Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials" @default.
W2105013371 cites W1493105257 @default.
W2105013371 cites W1549611683 @default.
W2105013371 cites W1692457515 @default.
W2105013371 cites W1979211241 @default.
W2105013371 cites W1990413669 @default.
W2105013371 cites W1990895663 @default.
W2105013371 cites W1994622746 @default.
W2105013371 cites W1997165312 @default.
W2105013371 cites W2005118637 @default.
W2105013371 cites W2007700273 @default.
W2105013371 cites W2009034973 @default.
W2105013371 cites W2046581108 @default.
W2105013371 cites W2060318706 @default.
W2105013371 cites W2060812248 @default.
W2105013371 cites W2071161597 @default.
W2105013371 cites W2074555962 @default.
W2105013371 cites W2078332534 @default.
W2105013371 cites W2081084828 @default.
W2105013371 cites W2094484039 @default.
W2105013371 cites W2102072512 @default.
W2105013371 cites W2107270081 @default.
W2105013371 cites W2107728866 @default.
W2105013371 cites W2109809089 @default.
W2105013371 cites W2111328291 @default.
W2105013371 cites W2132315278 @default.
W2105013371 cites W2135078918 @default.
W2105013371 cites W2142991244 @default.
W2105013371 cites W4293409513 @default.
W2105013371 doi "https://doi.org/10.1016/j.eururo.2013.04.020" @default.
W2105013371 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23628492" @default.
W2105013371 hasPublicationYear "2013" @default.
W2105013371 type Work @default.
W2105013371 sameAs 2105013371 @default.
W2105013371 citedByCount "50" @default.
W2105013371 countsByYear W21050133712013 @default.
W2105013371 countsByYear W21050133712014 @default.
W2105013371 countsByYear W21050133712015 @default.
W2105013371 countsByYear W21050133712016 @default.
W2105013371 countsByYear W21050133712017 @default.
W2105013371 countsByYear W21050133712018 @default.
W2105013371 countsByYear W21050133712019 @default.
W2105013371 countsByYear W21050133712020 @default.
W2105013371 countsByYear W21050133712021 @default.
W2105013371 countsByYear W21050133712022 @default.
W2105013371 countsByYear W21050133712023 @default.
W2105013371 crossrefType "journal-article" @default.
W2105013371 hasAuthorship W2105013371A5002009939 @default.
W2105013371 hasAuthorship W2105013371A5018275141 @default.
W2105013371 hasAuthorship W2105013371A5053854071 @default.
W2105013371 hasAuthorship W2105013371A5054920808 @default.
W2105013371 hasAuthorship W2105013371A5057812789 @default.
W2105013371 hasAuthorship W2105013371A5073246821 @default.
W2105013371 hasAuthorship W2105013371A5081220576 @default.
W2105013371 hasAuthorship W2105013371A5082556049 @default.
W2105013371 hasConcept C121608353 @default.
W2105013371 hasConcept C126322002 @default.
W2105013371 hasConcept C126894567 @default.
W2105013371 hasConcept C143998085 @default.
W2105013371 hasConcept C159110408 @default.
W2105013371 hasConcept C168563851 @default.
W2105013371 hasConcept C207103383 @default.
W2105013371 hasConcept C2776478404 @default.
W2105013371 hasConcept C2777899217 @default.
W2105013371 hasConcept C2778715236 @default.
W2105013371 hasConcept C2779951463 @default.
W2105013371 hasConcept C2780192828 @default.
W2105013371 hasConcept C44249647 @default.
W2105013371 hasConcept C71924100 @default.
W2105013371 hasConceptScore W2105013371C121608353 @default.
W2105013371 hasConceptScore W2105013371C126322002 @default.
W2105013371 hasConceptScore W2105013371C126894567 @default.
W2105013371 hasConceptScore W2105013371C143998085 @default.
W2105013371 hasConceptScore W2105013371C159110408 @default.
W2105013371 hasConceptScore W2105013371C168563851 @default.
W2105013371 hasConceptScore W2105013371C207103383 @default.
W2105013371 hasConceptScore W2105013371C2776478404 @default.
W2105013371 hasConceptScore W2105013371C2777899217 @default.
W2105013371 hasConceptScore W2105013371C2778715236 @default.
W2105013371 hasConceptScore W2105013371C2779951463 @default.
W2105013371 hasConceptScore W2105013371C2780192828 @default.
W2105013371 hasConceptScore W2105013371C44249647 @default.
W2105013371 hasConceptScore W2105013371C71924100 @default.
W2105013371 hasIssue "5" @default.
W2105013371 hasLocation W21050133711 @default.
W2105013371 hasLocation W21050133712 @default.